Advanced glycation end-products: a review
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Advanced glycation end-products are a complex and heterogeneous group of compounds that have been implicated in diabetes related complications. At present it is not known if they are the cause or the consequence of the complications observed. We discuss the chemistry of advanced glycated end-product formation and their patho-biochemistry particularly in relation to the diabetic microvascular complications of retinopathy, neuropathy and nephropathy as well as their role in the accelerated vasculopathy observed in diabetes. The concept of carbonyl stress as a cause for advanced glycated end-product toxicity is mentioned. We discuss alterations in the concentrations of advanced glycated end-products in the body, particularly in relation to changes occurring with age, diabetes and its complications such as nephropathy. Problems relating to current methods of advanced glycated end-product detection and measurement are highlighted including the lack of a universally established method of detection or unit of measurement. Agents used for the treatment of advanced glycated end-product accumulation are reviewed, with an emphasis on the results of the recent phase III trials using aminoguanidine and diabetes related complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“About 20 various AGEs have been detected in blood and tissues, as well as in foods.”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The most abundant non-fluorescence AGEs involve carboxymethyl-lysine (CML), and carboxyethyl-lysine (CEL). Fluorescence AGEs involve methylglyoxal-lysine and pentosidine (Singh et al. 2001).”
From Reactive Oxygen Species, Toxicity, Oxidative Stress, and Antioxidants: Chronic Diseases and Aging (2023) · cites this paper as Singh et al. 2001
In the citing paper
“The Maillard reaction generates these highly reactive dicarbonyls, also referred to as 𝛼-oxoaldehydes, which in addition to methylglyoxal include glyoxal and 3deoxyglucosone. [17]”
From The Role of Dietary Advanced Glycation End Products in Metabolic Dysfunction (2021) · cites this paper as [17]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, Y., Lalla, E., Fu, C., et al. (2000) · Nature · doi:10.1038/35012626 · Cited by 1,217
Koschinsky, T., He, C.-J., Mitsuhashi, T., Bucala, R., Liu, C., Buenting, C., Heitmann, K., & Vlassara, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.12.6474 · Cited by 792
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., & Lyons, T. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116482 · Cited by 444
Role of the Maillard Reaction in Aging of Tissue Proteins
Frye, E. B., Degenhardt, T. P., Thorpe, S. R., & Baynes, J. W. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.30.18714 · Cited by 366
Giardino, I., Edelstein, D., & Brownlee, M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117296 · Cited by 364
Glycation impairs high-density lipoprotein function
Hedrick, C. C., Thorpe, S. R., Fu, M.-X., Harper, C. M., Yoo, J., Kim, S.-M., Wong, H., & Peters, A. L. (2000) · Diabetologia · doi:10.1007/s001250050049 · Cited by 310
Research works printed but not linked: 2
- Kennedy L (1992) Glycation of immunoglobulins and serum proteins. In: Alberti KGMM, de Fronzo RA, Keen H, Zimmet P (eds) International Textbook of Dia- betes Mellitus, 2nd edn. John Wiley, Chichester pp 985±1007
- Neumann A, Schinzel R, Palm D, Riederer P, Munch G (1999) High molecular weight hyaluronic acid inhibits advanced glycation end-product induced NF-kappaB acti- vation and cytokine expression. FEBS Letters 453: 283±287
Cited by
Items 901–1,000 of 1,005
Giannetti, V., Mariani, M. B., & Colicchia, S. (2021) · Food Control · doi:10.1016/j.foodcont.2021.108036 · Cited by 39
Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus
Ying, L., Shen, Y., Zhang, Y., Wang, Y., Liu, Y., Yin, J., Wang, Y., Yin, J., Zhu, W., Bao, Y., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108880 · Cited by 40
The inhibitory effect of selenium nanoparticles on protein glycationin vitro
Yu, S., Zhang, W., Liu, W., Zhu, W., Guo, R., Wang, Y., Zhang, D., & Wang, J. (2015) · Nanotechnology · doi:10.1088/0957-4484/26/14/145703 · Cited by 38
“Fructosamine tested via a colorimetric test based on the ability of Amadori products to reduce NBT in alkaline solution to yield a colored monoformazan dye, is one of the Amadori products and usually used as a clinical indicator for short-term control of blood sugar in diabetic patients [3, 54].”
MethodElevated micronucleus frequency in patients with type 2 diabetes, dyslipidemia and periodontitis
Corbi, S. C. T., Bastos, A. D. S., Orrico, S. R. P., Secolin, R., Santos, R. A. D., Takahashi, C. S., & Scarel‐Caminaga, R. M. (2014) · Mutagenesis · doi:10.1093/mutage/geu043 · Cited by 44
Lund, T., Svindland, A., Pepaj, M., Jensen, A., Berg, J. P., Kilhovd, B. K., & Hanssen, K. F. (2011) · Diabetes and Vascular Disease Research · doi:10.1177/1479164111416831 · Cited by 42
IN VITRO ANTIGLYCATION ACTIVITY OF ARBUTIN
Jedsadayanmata, A. (2005) · Asian Health, Science and Technology Reports · Cited by 38
Stimulatory effects of advanced glycation endproducts (AGEs) on fibronectin matrix assembly
Pastino, A. K., Greco, T. M., Mathias, R. A., Cristea, I. M., & Schwarzbauer, J. E. (2016) · Matrix Biology · doi:10.1016/j.matbio.2016.07.003 · Cited by 41
“A series of reactions lead to the formation of advanced glycation endproducts (AGEs) [1,2] that modify arginine and lysine side chains as single adducts or as crosslinks between nearby residues [1].”
BackgroundJang, J., Kim, E., Park, H., Sung, E., Song, I., Kim, J., Woo, C.-H., Doh, K., Kim, K. H., & Lee, T. J. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13188 · Cited by 38
“Biological glycation has been investigated in the context of microvascular complications of diabetes, such as neuropathy, retinopathy and atherosclerosis [1].”
BackgroundDiabetes Mellitus and Heart Failure
Jagasia, D., & McNulty, P. H. (2003) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2002.00901.x · Cited by 38
Yang, F., Zhu, D., Wang, Z., Ma, Y., Huang, L., Kang, X., & Ma, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7299005 · Cited by 39
“AGEs are related to several age-related diseases [44].”
Sanshita, S., Devi, N., Bhattacharya, B., Sharma, A., Singh, I., Kumar, P., Huanbutta, K., & Sangnim, T. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s514247 · Cited by 46
“26 Reducing sugars react with amino groups of proteins (albumins, fibrinogens, and immunoglobulins) in the body, leading to the formation of a Schiff base.”
Modified Fast Procedure for the Detection and Screening of Antiglycative Phytochemicals
Wang, S., Chang, J., Pokkaew, R., Lee, J.-F., & Chiou, R. Y. ‐. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf201103t · Cited by 37
In vivo time-resolved autofluorescence measurements to test for glycation of human skin
Blackwell, J., Katika, K. M., Pilon, L., Dipple, K. M., Levin, S. R., & Nouvong, A. (2008) · Journal of Biomedical Optics · doi:10.1117/1.2830658 · Cited by 39
Role of dietary flavonoids in amelioration of sugar induced cataractogenesis
Patil, K. K., Meshram, R. J., Dhole, N. A., & Gacche, R. N. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.01.015 · Cited by 37
Deluyker, D., Ferferieva, V., Noben, J., Swennen, Q., Bronckaers, A., Lambrichts, I., Rigo, J., & Bito, V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.02.095 · Cited by 37
Zhong, C., Tan, S., & Langrish, T. A. G. (2018) · Journal of Food Engineering · doi:10.1016/j.jfoodeng.2018.09.020 · Cited by 37
Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative
Nagasawa, T., Tabata, N., Ito, Y., NISHIZAWA, N., Aiba, Y., & Kitts, D. D. (2003) · Springer eBooks · doi:10.1007/978-1-4419-9236-9_1 · Cited by 37
Jeyabal, P. V. S., Kumar, R., Gangula, P. R. R., Micci, M. ‐., & Pasricha, P. J. (2008) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2007.01018.x · Cited by 37
Li, L., Han, L., Fu, Q., Li, Y., Liang, Z., Su, J., & Li, B. (2012) · Molecules · doi:10.3390/molecules171112758 · Cited by 37
“AGEs are regarded a major pathological component in diabetes-related complications [4–6].”
BackgroundEnvironmental carcinogens and mutational pathways in atherosclerosis
Pulliero, A., Godschalk, R., Andreassi, M. G., Curfs, D. M. J., van Schooten, F., & Izzotti, A. (2015) · International Journal of Hygiene and Environmental Health · doi:10.1016/j.ijheh.2015.01.007 · Cited by 41
Huang, J., Chuang, L., Guh, J., Yang, Y., & Hsu, M.-S. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.09.002 · Cited by 37
AGEs trigger autophagy in diabetic skin tissues and fibroblasts
Sun, K., Wang, W., Wang, C., Lao, G., Liu, D., Mai, L., Yan, L., Yang, C. H., & Ren, M. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.020 · Cited by 37
Non-enzymatic glycation mediated structure–function changes in proteins: case of serum albumin
Awasthi, S., & Saraswathi, N. T. (2016) · RSC Advances · doi:10.1039/c6ra08283a · Cited by 41
Arterial stiffness is associated with diabetic retinopathy in type 2 diabetes
Ogawa, O., Hayashi, C., Nakaniwa, T., Tanaka, Y., & Kawamori, R. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.09.008 · Cited by 38
Valdes, M., Calzada, F., Martínez-Solís, J., & Martínez-Rodríguez, J. (2023) · Pharmaceuticals · doi:10.3390/ph16010112 · Cited by 37
“Then, 24 h later, the development of SIT2D was determined by measuring postprandial blood glucose levels using a conventional glucometer (ACCU-CHECK® Performa Blood Glucose Systems, Roche®, DC, Basel, Switzerland).”
BackgroundMethodInfluentialFarrag, E. A. E., Hammad, M. O., Safwat, S. M., Hamed, S. M., & Hellal, D. (2023) · Scientific Reports · doi:10.1038/s41598-023-37678-w · Cited by 39
Tack, W., Cock, A. D., Dirinck, E. L., Bastijns, S., Ariën, F., & Perkisas, S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15321 · Cited by 42
“66 AGEs already pile up in different tissues during the ageing process, but the co-morbid presence of T2D vastly accelerates this accumulation, as evidenced in both muscle biopsies and on skin autofluorescence.”
BackgroundChen, J., Arshi, B., Waqas, K., Lu, T., Bos, D., Ikram, M. A., Uitterlinden, A. G., Kavousi, M., & Zillikens, M. C. (2023) · Cardiovascular Diabetology · doi:10.1186/s12933-023-02052-7 · Cited by 41
“Advanced glycation end products (AGEs) have recently emerged as a novel actionable marker for diabetic cardiovascular complications [3].”
BackgroundGlycation of human erythrocyte glutathione peroxidase: Effect on the physical and kinetic properties
Suravajjala, S., Cohenford, M. A., Frost, L., Pampati, P. K., & Dain, J. A. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.02.032 · Cited by 36
Whitson, H. E., Arnold, A. M., Yee, L. M., Mukamal, K. J., Kizer, J. R., Djoussé, L., Ix, J. H., Siscovick, D. S., Tracy, R. P., Thielke, S. M., et al. (2013) · The Journals of Gerontology Series A · doi:10.1093/gerona/glt155 · Cited by 37
“AGEs constitute a heterogeneous group of biologically active compounds produced by the nonenzymatic glycation of proteins, lipids, and nucleic acids (3,4).”
BackgroundKandaraki, E., Chatzigeorgiou, A., Papageorgiou, E. G., Piperi, C., Adamopoulos, C., Papavassiliou, A. G., Koutsilieris, M., & Diamanti‐Kandarakis, E. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217731288 · Cited by 36
Narda, M., Peno‐Mazzarino, L., Krutmann, J., Trullàs, C., & Granger, C. (2018) · Skin Pharmacology and Physiology · doi:10.1159/000492276 · Cited by 36
Semenyuk, P., & Muronetz, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051252 · Cited by 33
“Glycation of positively charged residues (lysine and arginine) is a common non-enzymatic process occurring in living cells [184] as well as under artificial conditions such as food processing and cooking [185].”
BackgroundAli, M. Y., Zaib, S., Rahman, M., Jannat, S., Iqbal, J., Park, S. K., & Chang, M. S. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104061 · Cited by 38
Anti‐Diabetic Effects of Different Phenolic‐Rich Fractions from Rhus Chinensis Mill. Fruits in vitro
Liu, X., Fu, Y., Ma, Q., Yi, J., & Cai, S. (2021) · eFood · doi:10.2991/efood.k.210222.002 · Cited by 36
Zhao, M., Li, Y., Bai, X., Feng, J., Xia, X., & Li, F. (2022) · Foods · doi:10.3390/foods11162509 · Cited by 38
“GO, a kind of α-dicarbonyl compound, is a crucial precursor substance during the formation of AGEs [40], which is produced primarily through cleavage of the Schiff base, glucose oxidation, and lipid oxidation [41].”
BackgroundDifferential effects of advanced glycation end‐products on renal tubular cell inflammation
Tang, S. C. W., Chan, L. Y. Y., Leung, J. C. K., Cheng, A., Lin, M. Y., Lan, H. Y., & Lai, K. N. (2010) · Nephrology · doi:10.1111/j.1440-1797.2010.01437.x · Cited by 36
“Of importance in this reaction is the formation of reactive intermediate products known as a-dicarbonyls such as methylglyoxal and 3-deoxyglucosone (3-DG) that may ultimately lead to stable covalent adducts known as advanced glycation endproducts (AGE).(10) In humans, irreversible advanced glycation is a part of the a…”
BackgroundZhou, Y., Lin, Q., Jin, C. W., Cheng, L., Zheng, X., Dai, M., & Zhang, Y. (2015) · Journal of Food Science · doi:10.1111/1750-3841.12744 · Cited by 36
The role of post‐translational modifications in acute and chronic cardiovascular disease
Smith, L. E., & White, M. Y. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201400052 · Cited by 37
“Structural proteins within the extracellular matrix (ECM) are often modified by AGEs, due to both their stability and exposure to hyperglycemic environments [93, 94].”
BackgroundAssociation of the Ser326Cys polymorphism in the OGG1 gene with type 2 DM
Daimon, M., Oizumi, T., Toriyama, S., Karasawa, S., Jimbu, Y., Wada, K., Kameda, W., Susa, S., Muramatsu, M., Kubota, I., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.119 · Cited by 36
Reduced Dermis Thickness and AGE Accumulation in Diabetic Abdominal Skin
Niu, Y., Cao, X., Song, F., Xie, T., Ji, X., Miao, M., Dong, J., Tian, M., Lin, Y., & Lu, S. (2012) · The International Journal of Lower Extremity Wounds · doi:10.1177/1534734612457570 · Cited by 36
“AGE generation is accelerated in pathological conditions characterized by hyperglycemia and/or oxidative stress and is known to contribute to pathologies associated with long-term complications of diabetes.(1,6) The slow turnover rate of macromolecular collagen in Extracellular Matrix (ECM), which are found richly in…”
BackgroundPark, C. H., Yokozawa, T., & Noh, J. S. (2014) · Journal of Nutrition · doi:10.3945/jn.114.193961 · Cited by 36
Maietta, M., Colombo, R., Corana, F., & Papetti, A. (2018) · Food & Function · doi:10.1039/c7fo01930k · Cited by 36
Recent Advances in the Modification and Improvement of Bioprosthetic Heart Valves
Tong, Q., Cai, J., Wang, Z., Sun, Y., Liang, X., Xu, Q., Mahamoud, O. A., Qian, Y., & Qian, Z. (2024) · Small · doi:10.1002/smll.202309844 · Cited by 38
Engelbertsen, D., Anand, D. V., Fredrikson, G. N., Hopkins, D., Corder, R., Shah, P. K., Lahiri, A., Nilsson, J., & Bengtsson, E. (2011) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2011.02411.x · Cited by 35
Role of Advanced Glycation Endproducts and Potential Therapeutic Interventions in Dialysis Patients
Mallipattu, S. K., He, C., & Uribarri, J. (2012) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2012.01081.x · Cited by 38
Westermeier, F., Puebla, C., Vega, J. L., Farías, M., Escudero, C., Casanello, P. C., & Sobrevía, L. (2009) · Current Vascular Pharmacology · doi:10.2174/157016109789043900 · Cited by 36
Jagdale, A. D., Bavkar, L. N., More, T., Joglekar, M. M., & Arvindekar, A. U. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.01.001 · Cited by 35
Osawa, S., Katakami, N., Kuroda, A., Takahara, M., Sakamoto, F., Kawamori, D., Matsuoka, T., Matsuhisa, M., & Shimomura, I. (2016) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.35592 · Cited by 37
Revisiting amino acids and peptides as anti-glycation agents
Chilukuri, H., Kulkarni, M. J., & Fernandes, M. (2018) · MedChemComm · doi:10.1039/c7md00514h · Cited by 38
Advances in PCOS Pathogenesis and Progression—Mitochondrial Mutations and Dysfunction
Ilie, I. R. P. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.05.003 · Cited by 38
Effect of taxifolin on development of retinopathy in alloxan-induced diabetic rats
Ahiskali, I., Pinar, C. L., Kiki, M., Mammadov, R., Bilgin, A. Ö., Hacımüftüoğlu, A., Çankaya, M., Çimen, F. K., & Altuner, D. (2019) · Cutaneous and Ocular Toxicology · doi:10.1080/15569527.2019.1588289 · Cited by 35
Huang, J., Ren, J., Tao, G., Chen, Y., Yao, S., Han, D., & Qiu, R. (2019) · Food Research International · doi:10.1016/j.foodres.2019.04.040 · Cited by 38
Hajizadeh‐Sharafabad, F., Sahebkar, A., Zabetian‐Targhi, F., & Maleki, V. (2019) · BioFactors · doi:10.1002/biof.1531 · Cited by 35
Mechanism of protein cleavage at asparagine leading to protein–protein cross-links
Friedrich, M. G., Wang, Z., Schey, K. L., & Truscott, R. J. W. (2019) · Biochemical Journal · doi:10.1042/bcj20190743 · Cited by 35
Evaluating Alternatives to Water as Solvents for Life: The Example of Sulfuric Acid
Bains, W., Petkowski, J. J., Zhan, Z., & Seager, S. (2021) · Life · doi:10.3390/life11050400 · Cited by 40
Skin optical properties in the obese and their relation to body mass index: a review
Rodriguez, A. J., Boonya-Ananta, M. T., Gonzalez, M., Le, V. N. D., Fine, J. N., Palacios, C. S., McShane, M. J., Coté, G. L., & Ramella‐Roman, J. C. (2022) · Journal of Biomedical Optics · doi:10.1117/1.jbo.27.3.030902 · Cited by 40
Tuell, D. S., LOS, E. A., Ford, G. A., & Stone, W. L. (2023) · Antioxidants · doi:10.3390/antiox12061139 · Cited by 36
“Glucose can covalently react with lysine, arginine, and N-terminal residues on proteins to form glycation adducts which can further react to form advanced glycation end products (AGEs) [27].”
BackgroundAdvanced Glycation Endproducts and Rat Dental Implant Osseointegration
Quintero, D. G., Winger, J. N., Khashaba, R. M., & Borke, J. L. (2010) · Journal of Oral Implantology · doi:10.1563/aaid-joi-d-09-00032 · Cited by 46
Nahomi, R. B., Oya‐Ito, T., & Nagaraj, R. H. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.08.015 · Cited by 35
Study on the characteristic of bovine serum albumin-glucose model system, treated by ultrasonic
Shi, W., Sun, W.-W., Yu, S., & Zhao, M. (2010) · Food Research International · doi:10.1016/j.foodres.2010.07.020 · Cited by 35
Dhanya, B. L., Swathy, R. P., & Indira, M. (2014) · Biological Trace Element Research · doi:10.1007/s12011-014-0076-7 · Cited by 36
“AGEs accumulate during aging and accelerate during the course of diabetes [6].”
BackgroundCheng, G., Wang, L., Long, L., Liu, H., Cui, H. Z., Qu, W., & Li, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707533 · Cited by 37
“Finally, the myocardial and vascular systems become less flexible, which in turn contributes to the cardiovascular dysfunction observed in diabetic complications (Brownlee et al., 1988a; Norton et al., 1996; Avendano et al., 1999; Singh et al., 2001).”
BackgroundSundl, I., Roob, J. M., Meinitzer, A., Tiran, B., Khoschsorur, G., Haditsch, B., Holzer, H., & Winklhofer‐Roob, B. M. (2009) · Peritoneal Dialysis International · doi:10.1177/089686080902900113 · Cited by 35
“Fasting glucose concentrations were significantly higher in patients with diabetes mellitus compared to patients without, but significant differences were not found for plasma pentosidine, MDA, CRP, IL-6, or for the antioxidants α- and γ-tocopherol, ascorbate, and carotenoids (data not shown).”
BackgroundInfluentialPetersen, K. E., Rakipovski, G., Raun, K., & Lykkesfeldt, J. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666150918150608 · Cited by 38
Yang, C., Meng, F., Chen, L., Li, X., Cen, L., Wen, Y., Zhang, H., & Li, C. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000458734 · Cited by 35
Molecular susceptibility to glycation and its implication in diabetes mellitus and related diseases
Méndez, J. D., Xie, J., Aguilar-Hernández, M., & Méndez-Valenzuela, V. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0541-3 · Cited by 37
“During the second stage, products from the first stage are converted into intermediates such as a-dicarbonyls or oxoaldehydes [ 2 ], which are comprised of derivates of reducing sugars, aldehydes, a-ketoaldehydes, and cyclic structures [3].”
BackgroundTechniques for studying protein heterogeneity and post-translational modifications
Baumann, M., & Meri, S. (2004) · Expert Review of Proteomics · doi:10.1586/14789450.1.2.207 · Cited by 35
The Role of Advanced Glycation End-Products in Cancer Disparity
Turner, D. P. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2016.08.001 · Cited by 36
The LepRdb/db mice model for studying glycation in the context of diabetes
Guilbaud, A., Howsam, M., Niquet‐Léridon, C., Delguste, F., Boulanger, É., & Tessier, F. J. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3103 · Cited by 37
“Glycation is a nonenzymatic reaction between reducing sugars (eg, glucose and fructose) and amine functional groups in proteins, peptides, or amino acids (preferentially lysine and arginine).(5) The”
BackgroundPeli1 induction impairs cardiac microvascular endothelium through Hsp90 dissociation from IRE1α
Zhao, Q., Yang, J., Chen, H., Li, J., Que, L., Zhu, G., Liu, L., Ha, T., Chen, Q., Li, C., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.06.017 · Cited by 36
Anthony‐Regnitz, C. M., Wilson, A. E., Sweazea, K. L., & Braun, E. J. (2020) · Journal of Molecular Evolution · doi:10.1007/s00239-020-09964-y · Cited by 34
p21-Activated kinase 1 (PAK1) in aging and longevity: An overview
Mohankumar, A., Sundararaj, P., & Tawata, S. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101443 · Cited by 37
Effects of Genistein on Common Kidney Diseases
Peng, Q., Li, Y., Shang, J., Huang, H., Zhang, Y., Ding, Y., Liang, Y., Xie, Z., & Chen, C. (2022) · Nutrients · doi:10.3390/nu14183768 · Cited by 35
Yan, S., Wang, L., Li, Z., Zhu, D., Guo, S.-C., Xin, W., Yang, Y., Cong, X., Ma, T., Shen, P.-P., et al. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf300347p · Cited by 34
Impaired synthesis contributes to diabetes-induced decrease in liver glutathione
Traverso, N. (2012) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2012.915 · Cited by 37
“Several studies have underlined the participation of oxidative mechanisms in the generation of some advanced glycation end-products (AGE) (7), which are considered responsible for protein alterations leading to diabetic sequelae (8).”
Kumar, P. A., Welsh, G. I., Raghu, G., Menon, R. K., Saleem, M. A., & Reddy, G. B. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.003 · Cited by 33
Pathogenesis and Novel Treatment from the Mouse Model of Type 2 Diabetic Nephropathy
Furukawa, M., Gohda, T., Tanimoto, M., & Tomino, Y. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/928197 · Cited by 34
Gonzalez, A. D., Gallant, M. A., Burr, D. B., & Wallace, J. M. (2013) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2013.11.045 · Cited by 37
“One such mechanism is the formation of advanced glycation end products (AGEs) (Singh et al. 2001).”
Yu, L., He, Z., Zeng, M., Zheng, Z., He, J., Wang, M., & Chen, J. (2015) · International Journal of Food Science & Technology · doi:10.1111/ijfs.13016 · Cited by 34
Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative
Nagasawa, T., Tabata, N., Ito, Y., NISHIZAWA, N., Aiba, Y., & Kitts, D. D. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/a:1024793429244 · Cited by 40
“AGEs are known to accumulate in both plasma proteins and slow turnover tissue protein sources such as collagen and lens of aged and diabetic subjects [2–10].”
BackgroundTyrberg, B., Anachkov, K. A., Dib, S. A., Wang‐Rodriguez, J., Yoon, K., & Levine, F. (2002) · BMC Endocrine Disorders · doi:10.1186/1472-6823-2-2 · Cited by 37
“Glucose also leads to advanced glycation end products, which initiate free radical cascades and are toxic to cells, including β-cells [27,28].”
BackgroundSite‐specific synthesis of Amadori‐modified peptides on solid phase
Frolov, A., Singer, D. L., & Hoffmann, R. (2005) · Journal of Peptide Science · doi:10.1002/psc.739 · Cited by 34
“They gradually undergo irreversible transformations yielding various advanced glycation end products (AGEs) that are in different oxidation and degradation states [4].”
BackgroundWan, J., Liang, Y., Hu, Q., Liang, Z., Feng, W., Tian, Y., Li, S., Ye, Z., Hong, M., Han, D., et al. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.3c03052 · Cited by 33
Potassium sorbate as an AGE activator for human serum albumin in the presence and absence of glucose
Taghavi, F., Moosavi‐Movahedi, A. A., Bohlooli, M., Hadi‐Alijanvand, H., Salami, M., Maghami, P., Saboury, A. A., Farhadi, M. R., Yousefi, R., Habibi-Rezaei, M., et al. (2013) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2013.08.045 · Cited by 33
Wood, R. J., & O’Neill, E. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/268197 · Cited by 39
A novel improved therapy strategy for diabetic nephropathy: Targeting AGEs
Zhou, X., Wang, B., Zhu, L., & Hao, S. (2012) · Organogenesis · doi:10.4161/org.19332 · Cited by 36
Abdullah, K. M., Qais, F. A., Ahmad, I., & Naseem, I. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.06.009 · Cited by 36
Barman, S., & Srinivasan, K. (2018) · Biological Trace Element Research · doi:10.1007/s12011-018-1373-3 · Cited by 33
“Protein glycation and accumulation of AGEs are accompanied by intensified free radical action which leads to biomolecular impairment such as modified enzymatic activity and protein half-life in diabetic eye tissue [35, 36].”
BackgroundSkin autofluorescence is associated with vascular complications in patients with type 2 diabetes
Osawa, S., Katakami, N., Sato, I., Ninomiya, H., Omori, K., Yamamoto, Y., Takahara, M., Miyashita, K., Sakamoto, F., Kawamori, D., et al. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.06.009 · Cited by 35
Becker, J., Mahlke, N. S., Reckert, A., Eickhoff, S. B., & Ritz‐Timme, S. (2019) · International Journal of Legal Medicine · doi:10.1007/s00414-019-02054-9 · Cited by 34
Yoshikata, R., Myint, K. Z. Y., Ohta, H., & Ishigaki, Y. (2021) · PLoS ONE · doi:10.1371/journal.pone.0257332 · Cited by 37
Muraoka, M. Y., Justino, A. B., Caixeta, D. C., Queiroz, J. S., Silva, R. S., & Espíndola, F. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262369 · Cited by 34
“…refers to a sequence of non-enzymatic reactions that begin when reducing sugars such as glucose and fructose react with nucleophilic groups of amino acids from proteins, lipids or nucleic acids forming Schiff bases and Amadori products to produce advanced glycation end products (AGEs) [1,2].”
Advanced protein glycation in psoriasis
Damasiewicz-Bodzek, A., & Wielkoszyński, T. (2011) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2011.04024.x · Cited by 36
Navarro, M., & Morales, F. J. (2014) · Food Chemistry · doi:10.1016/j.foodchem.2014.11.117 · Cited by 33
Dong, Q., Banaich, M. S., & O’Brien, P. J. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.03.003 · Cited by 33
Factors influencing arterial stiffness in pheochromocytoma and effect of adrenalectomy
Petrák, O., Štrauch, B., Zelinka, T., Rosa, J., Holaj, R., Vranková, A., Kasalicky, M., Kvasnička, J., Pacák, K., & Widimsky, J., Jr. (2010) · Hypertension Research · doi:10.1038/hr.2010.12 · Cited by 33
Physicochemical analysis of structural changes in DNA modified with glucose
Ashraf, J. M., Arif, B., Dixit, K., Moinuddin, M., & Alam, K. (2012) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2012.06.013 · Cited by 33
Stratmann, B., Goldstein, B., Thornalley, P. J., Rabbani, N., & Tschoepe, D. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030480 · Cited by 33
Harsha, P. S. C. S., & Lavelli, V. (2019) · Nutrients · doi:10.3390/nu11081917 · Cited by 38
“AGEs have also been found to be involved in cardiovascular diseases [2,3], chronic renal diseases [4], chronic liver diseases and hepatocellular carcinoma [7].”
BackgroundInfluential
Metadata
- Authors
- Singh, R., Barden, A., Mori, T., & Beilin, L.
- Affiliations
- The University of Western Australia (AU)
- Venue
- Diabetologia
- Published
- 2001-02-05
- Volume
- 44
- Issue
- 2
- Pages
- 129-146
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W1966234811
- Cited by
- 2,597
- References
- 45
- Citations by year
- 2026: 67 · 2025: 85 · 2024: 124 · 2023: 117 · 2022: 152 · 2021: 161 · 2020: 138 · 2019: 142 · 2018: 118 · 2017: 118 · 2016: 130 · 2015: 139 · 2014: 132 · 2013: 114 · 2012: 132
- FWCI
- 36.26
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-04-30)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Funders
- Medical Research Council
- National Health and Medical Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Keywords
- advanced glycation end products, diabetes complications, diabetic microvascular complications, diabetic retinopathy, diabetic neuropathy, diabetic nephropathy, diabetic vascular disease, carbonyl stress, aminoguanidine
- MeSH terms
- Receptor for Advanced Glycation End Products, Aging, Diabetes Mellitus, Diabetic Nephropathies, Diabetic Neuropathies, Diabetic Retinopathy, Food, Humans, Plants, Toxic, Receptors, Immunologic, Nicotiana, Glycation End Products, Advanced
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.